{
  "retracted": false,
  "timestamp": 1519344000000,
  "updates": [
    {
      "timestamp": 1585527172907,
      "identifier": {
        "doi": "10.1007/s40273-018-0634-5"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40273-017-0557-6"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Author Correction to: Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy"
}
